Harlem Biospace (Hb) is a new biotech incubator that provides up to 24 competitively-selected, early-stage life science companies access to affordable wet lab, microbench space, specialized laboratory equipment, mentorship, business support, and programming.
Its goal is to create a thriving biotech community in New York City that helps turn revolutionary biotech ideas into products that solve real health problems. The Harlem Biospace is located at 423 West 127th Street in a 2,300 SF ground-floor space near Columbia University, Columbia's new Manhattanville campus, and City College, and is easily accessible to New York City’s major academic and research institutions. NYCEDC developed this incubator in partnership with Sam Sia, PhD, an entrepreneur and faculty member at Columbia University’s Department of Biomedical Engineering and Founder of Harlem Biospace. Its advisory board consists of leading life science companies and venture capital firms including Pfizer, Johnson & Johnson, GlaxoSmithKline, New Leaf Ventures, OrbiMed, and Siemens Healthcare Diagnostics.
The incubator launched in November 2013. Learn more about this new, exciting space at harlembiospace.com
Harlem Biospace's K-12 STEM initiative, HYPOTHEkids, prepares the next generation of life science talent by teaching NYC students about the scientific method, bioengineering and entrepreneurship.
Photos from the summer 2014 HYPOTHEkids session: